Previous close | 2.8400 |
Open | 2.8200 |
Bid | 2.5000 x 3200 |
Ask | 3.0500 x 3000 |
Day's range | 2.7750 - 2.8600 |
52-week range | 2.3500 - 5.4000 |
Volume | 383,551 |
Avg. volume | 482,187 |
Market cap | 250M |
Beta (5Y Monthly) | 2.03 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.1880 |
Earnings date | 20 Jan 2020 - 24 Jan 2020 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 6.88 |
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intuitive Surgical (ISRG) is likely to strengthen its da Vinci surgical system with the recent FDA nod.
In this article we are going to estimate the intrinsic value of Accuray Incorporated (NASDAQ:ARAY) by estimating the...
Accuray (ARAY) reiterates revenue and adjusted EBITDA view for fiscal 2020.
Accuray (ARAY) delivered earnings and revenue surprises of -10.00% and -4.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
AngioDynamics (ANGO) is likely to see an expansion of its already existing VIT product portfolio with the buyout of Eximo Medical.
Luminex (LMNX) receives FDA clearance for the ARIES MRSA assay, which is likely to provide a boost to the company's ARIES platform.
Accuray Incorporated (NASDAQ:ARAY), which is in the medical equipment business, and is based in United States, saw a...
A number of MedTech companies are currently attempting to gain ground within the robotics-aided healthcare market.
Accuray's (ARAY) CyberKnife delivers stereotactic body radiation therapy in only five sessions.
Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Accuray (ARAY) slashes fiscal 2020 revenue guidance owing to tariffs in China.
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
Disappointing fourth-quarter results are taking a toll on the medical device stock.
Accuray (ARAY) expects fiscal 2020 revenues to be impacted by China tariffs.
The CyberKnife maker missed Wall Street bottom-line estimates and announced disappointing guidance for fiscal 2020.
ARAY earnings call for the period ending June 30, 2019.
Accuray (ARAY) delivered earnings and revenue surprises of -166.67% and 1.14%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
In 2012 Joshua Levine was appointed CEO of Accuray Incorporated (NASDAQ:ARAY). First, this article will compare CEO...
Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you're interested in Accuray Incorporated (NASDAQ:ARAY), then you might want to consider its beta (a measure of...
Every investor in Accuray Incorporated (NASDAQ:ARAY) should be aware of the most powerful shareholder groups...
The NAMIC fluid management portfolio sale clears all of AngioDynamics' (ANGO) outstanding debt.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The main aim of stock picking is to find the market-beating stocks. But every investor is virtua...